DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 129 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q2 2019. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,037,000 | -63.6% | 280,168 | -52.7% | 0.02% | -63.0% |
| Q4 2021 | $8,332,000 | -33.0% | 592,156 | -8.5% | 0.05% | -42.5% |
| Q3 2021 | $12,433,000 | +7344.9% | 647,241 | +3708.0% | 0.08% | +7900.0% |
| Q2 2021 | $167,000 | -72.6% | 16,997 | -72.6% | 0.00% | -75.0% |
| Q1 2021 | $610,000 | +320.7% | 62,038 | +278.3% | 0.00% | +100.0% |
| Q2 2020 | $145,000 | -73.1% | 16,400 | -77.8% | 0.00% | -87.5% |
| Q1 2019 | $539,000 | -62.3% | 73,795 | +11.1% | 0.02% | -50.0% |
| Q3 2017 | $1,429,000 | – | 66,448 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
| Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
| PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
| Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
| Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
| FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
| FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
| Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
| OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |